IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

European Journal of Cancer, Supplement

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on September 3, 2024

Impact Score

2023-2024

0.33

h-Index

2023-2024

 29

Rank

2023-2024

 6710

SJR

2023-2024

 0.759

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title European Journal of Cancer, Supplement
Abbreviation Eur. J. Cancer Suppl.
Publication Type Journal
Subject Area, Categories, Scope Oncology (Q2); Cancer Research (Q3)
h-index 29
Overall Rank/Ranking 6710
SCImago Journal Rank (SJR) 0.759
Impact Score 0.33
Publisher Elsevier Ltd
Country United Kingdom
ISSN 18781217, 13596349
Best Quartile Q2
Coverage History 2003-2016, 2020-2021




About European Journal of Cancer, Supplement


European Journal of Cancer, Supplement is a journal covering the technologies/fields/categories related to Oncology (Q2); Cancer Research (Q3). It is published by Elsevier Ltd. The overall rank of European Journal of Cancer, Supplement is 6710. According to SCImago Journal Rank (SJR), this journal is ranked 0.759. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 29. The best quartile for this journal is Q2.

The ISSN of European Journal of Cancer, Supplement journal is 18781217, 13596349. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. European Journal of Cancer, Supplement is cited by a total of 31 articles during the last 3 years (Preceding 2023).


European Journal of Cancer, Supplement Impact IF 2023-2024


The Impact IF 2023 of European Journal of Cancer, Supplement is 0.33, which is computed in 2024 as per its definition. European Journal of Cancer, Supplement IF is decreased by a factor of 1.6 and approximate percentage change is -82.9% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

European Journal of Cancer, Supplement Impact IF 2024 Prediction


Impact IF 2023 of European Journal of Cancer, Supplement is 0.33. If the same downward trend persists, Impact IF may fall in 2024 as well.


Impact IF Trend


Year wise Impact IF of European Journal of Cancer, Supplement. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2023 0.33
2022 1.93
2021 1.36
2020 0.00
2019 0.00
2018 9.00
2017 0.30
2016 2.38
2015 0.53
2014 0.19

European Journal of Cancer, Supplement h-index


  Table Setting

European Journal of Cancer, Supplement has an h-index of 29. It means 29 articles of this journal have more than 29 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




European Journal of Cancer, Supplement ISSN


The ISSN of European Journal of Cancer, Supplement is 18781217, 13596349. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

European Journal of Cancer, Supplement Rank and SCImago Journal Rank (SJR)


The overall rank of European Journal of Cancer, Supplement is 6710. According to SCImago Journal Rank (SJR), this journal is ranked 0.759. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of European Journal of Cancer, Supplement by Year


Year SJR
2023/2024 Coming Soon
2023 0.759
2022 0.571
2021 0.248
2020
2019 0.383
2018 0.256
2017 1.358
2016 0.942
2015 0.221
2014 0.136

Ranking of European Journal of Cancer, Supplement by Year


Year Ranking
2023/2024 Coming Soon
2023 6710
2022 9063
2021 16486
2020 33274
2019 12120
2018 15247
2017 2725
2016 4782
2015 16404
2014 22066

European Journal of Cancer, Supplement Publisher


Table Setting

European Journal of Cancer, Supplement is published by Elsevier Ltd. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2003-2016, 2020-2021. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of European Journal of Cancer, Supplement is Eur. J. Cancer Suppl.. This abbreviation ('Eur. J. Cancer Suppl.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in European Journal of Cancer, Supplement


If your research field is/are related to Oncology (Q2); Cancer Research (Q3), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the European Journal of Cancer, Supplement?

European Journal of Cancer, Supplement latest impact IF is 0.33. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 9.00 (2018) and 0.00 (2020), respectively, in the last 10 years. Moreover, its average IS is 1.6 in the previous 10 years.


What's the SCImago Journal Rank (SJR) of the European Journal of Cancer, Supplement?

The European Journal of Cancer, Supplement has an SJR (SCImago Journal Rank) of 0.759, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 1.358 in 2017 and the lowest being in 2020. Furthermore, the average SJR of the European Journal of Cancer, Supplement over the previous 10-year period stands at 1.6.


What's the latest h-index of the European Journal of Cancer, Supplement?

The latest h-index of the European Journal of Cancer, Supplement is 29.


Who's the publisher of the European Journal of Cancer, Supplement?

The European Journal of Cancer, Supplement is published by the Elsevier Ltd, with its country of publication being the United Kingdom.


What's the current ranking of the European Journal of Cancer, Supplement?

The European Journal of Cancer, Supplement is currently ranked 6710 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 2725 in 2017 and its lowest position of 33274 in 2020.


What's the abbreviation or short name for the European Journal of Cancer, Supplement?

The standard ISO4 abbreviation for the European Journal of Cancer, Supplement is Eur. J. Cancer Suppl..


Is the "European Journal of Cancer, Supplement" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

European Journal of Cancer, Supplement is classified as a journal that the Elsevier Ltd publishes.


What's the scope or major areas of the European Journal of Cancer, Supplement?

The European Journal of Cancer, Supplement encompasses the following areas:

  • Oncology
  • Cancer Research

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the European Journal of Cancer, Supplement?

The European Journal of Cancer, Supplement is assigned the following International Standard Serial Numbers (ISSN): 18781217, 13596349.


What's the best quartile of the European Journal of Cancer, Supplement?

The best quartile for the European Journal of Cancer, Supplement is Q2 (2023).


What's the coverage history of the European Journal of Cancer, Supplement?

The European Journal of Cancer, Supplement coverage history can be summarized as follows: 2003-2016, 2020-2021.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
European Union Politics journal 2569 SAGE Publications Ltd 75 3.24
Historia journal 28724 Universidade Estadual Paulista 8 0.02
Revue Francophone des Laboratoires (discontinued) journal 23244 Elsevier Masson s.r.l. 8 0.00
Criminal Justice Review journal 12054 SAGE Publications Inc. 42 1.10
Child and Family Social Work journal 8089 Wiley-Blackwell Publishing Ltd 75 2.10
Canadian Journal of Education journal 18985 Canadian Society for the Study of Education (CSSE) 43 0.58
British Journal of Special Education journal 16076 Wiley-Blackwell Publishing Ltd 44 0.78
International Journal of Research and Method in Education journal 5876 Taylor and Francis Ltd. 38 2.50
Korean Journal of Applied Microbiology and Biotechnology journal 22033 Korean Society for Applied Microbiology 0 0.00
Indian Phytopathology journal 15501 Springer Nature 16 1.09

Check complete list




Year wise Impact Score (IS) of European Journal of Cancer, Supplement

Impact Score Table

Year Impact Score (IS)
2024/2025 Coming Soon
2023 0.33
2022 1.93
2021 1.36
2020 0.00
2019 0.00
2018 9.00
2017 0.30
2016 2.38
2015 0.53
2014 0.19



Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Annals of Oncology
Elsevier Ltd | United Kingdom

Lancet Oncology, The
Elsevier Ltd | United Kingdom

Nature Cancer
Nature Research | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Molecular Cancer
BioMed Central Ltd | United Kingdom

Journal of Thoracic Oncology
Elsevier Inc. | United States

See All

Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Nature Cancer
Nature Research | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Molecular Cancer
BioMed Central Ltd | United Kingdom

JAMA Oncology
American Medical Association | United States

Cell Host and Microbe
Cell Press | United States

Journal of Hematology and Oncology
BioMed Central Ltd | United Kingdom

Neuro-Oncology
Oxford University Press | United Kingdom

See All